CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell line

por Norouzi-Barough, Leyla, Sarookhani, Mohammadreza, Salehi, Rasoul, Sharifi, Mohammadreza, Moghbelinejad, Sahar
Publicado 2018